NCT00507663View on ClinicalTrials.gov

Elder Surgery - Functional Recovery Following Beta Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Post Operative Cognitive Dysfunction
Interventions
DRUG

Atenolol

Patients with a standing prescription for β-blockers will be continued on that medication. Pts not currently receiving a beta blocker will be given 50mg of atenolol on the morning of surgery, 50-100mg, twice per day, on the first postoperative day until postoperative day 7.

Trial Locations (3)

10016

NYU School of Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

55905

The Mayo Clinic, Rochester

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT00507663 - Elder Surgery - Functional Recovery Following Beta Blockade | Biotech Hunter | Biotech Hunter